Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex
Epidermolysis bullosa simplex (EBS) is a group of inherited keratinopathies that, in most cases, arise due to mutations in keratins and lead to intraepidermal ruptures. The cellular pathology of most EBS subtypes is associated with the fragility of the intermediate filament network, cytolysis of the basal layer of the epidermis, or attenuation of hemidesmosomal/desmosomal components. Mutations in keratins 5/14 or in other genes that encode associated proteins induce structural disarrangements of different strengths depending on their locations in the genes. Keratin aggregates display impaired dynamics of assembly and diminished solubility and appear to be the trigger for endoplasmic reticulum (ER) stress upon being phosphorylated by MAPKs. Global changes in cellular signaling mainly occur in cases of severe dominant EBS mutations. The spectrum of changes initiated by phosphorylation includes the inhibition of proteasome degradation, TNF-α signaling activation, deregulated proliferation, abnormal cell migration, and impaired adherence of keratinocytes. ER stress also leads to the release of proinflammatory danger-associated molecular pattern (DAMP) molecules, which enhance avalanche-like inflammation. Many instances of positive feedback in the course of cellular stress and the development of sterile inflammation led to systemic chronic inflammation in EBS. This highlights the role of keratin in the maintenance of epidermal and immune homeostasis.
Top-30
Journals
|
1
2
3
4
|
|
|
Journal of Investigative Dermatology
4 publications, 12.12%
|
|
|
Scientific Reports
2 publications, 6.06%
|
|
|
International Journal of Molecular Sciences
2 publications, 6.06%
|
|
|
Frontiers in Pharmacology
1 publication, 3.03%
|
|
|
Frontiers in Cell and Developmental Biology
1 publication, 3.03%
|
|
|
JEADV Clinical Practice
1 publication, 3.03%
|
|
|
Journal of the European Academy of Dermatology and Venereology
1 publication, 3.03%
|
|
|
Nature Cell Biology
1 publication, 3.03%
|
|
|
Current Opinion in Cell Biology
1 publication, 3.03%
|
|
|
Journal of Dermatology
1 publication, 3.03%
|
|
|
Cornea
1 publication, 3.03%
|
|
|
JAAD Case Reports
1 publication, 3.03%
|
|
|
bioRxiv
1 publication, 3.03%
|
|
|
Histochemistry and Cell Biology
1 publication, 3.03%
|
|
|
BMC Biology
1 publication, 3.03%
|
|
|
Global Challenges
1 publication, 3.03%
|
|
|
Frontiers in Plant Science
1 publication, 3.03%
|
|
|
APL Bioengineering
1 publication, 3.03%
|
|
|
Orphanet Journal of Rare Diseases
1 publication, 3.03%
|
|
|
Expert Opinion on Biological Therapy
1 publication, 3.03%
|
|
|
International Journal of Dermatology
1 publication, 3.03%
|
|
|
European Journal of Medical Research
1 publication, 3.03%
|
|
|
British Journal of Dermatology
1 publication, 3.03%
|
|
|
Cancers
1 publication, 3.03%
|
|
|
Human Molecular Genetics
1 publication, 3.03%
|
|
|
1
2
3
4
|
Publishers
|
1
2
3
4
5
6
7
|
|
|
Springer Nature
7 publications, 21.21%
|
|
|
Elsevier
7 publications, 21.21%
|
|
|
Wiley
5 publications, 15.15%
|
|
|
MDPI
3 publications, 9.09%
|
|
|
Frontiers Media S.A.
3 publications, 9.09%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 6.06%
|
|
|
Oxford University Press
2 publications, 6.06%
|
|
|
IntechOpen
1 publication, 3.03%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 3.03%
|
|
|
AIP Publishing
1 publication, 3.03%
|
|
|
Taylor & Francis
1 publication, 3.03%
|
|
|
1
2
3
4
5
6
7
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.